Literature DB >> 15460529

E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach.

G Di Bonaventura1, C Picciani, I Spedicato, R Piccolomini.   

Abstract

The aim of this study was to evaluate the accuracy of E-test for the detection of synergy or antagonism of antibiotic combinations against Pseudomonas aeruginosa isolates from neutropenic patients. The activity of levofloxacin or grepafloxacin combined with ceftriaxone or cefotaxime against 20 P. aeruginosa clinical strains was assessed by checkerboard technique in comparison with results performed by E-test. The combination grepafloxacin + ceftriaxone appeared to be most effective (synergy, 55%) by checkerboard technique. The agreement between checkerboard and E-test results was 71.2%. Synergy was detected by checkerboard and E-test methods in 35 (43.8%) and 23 (31.3%) of 80 possible combinations, respectively. Antagonism was detected once (1.2%) by checkerboard method only. No major errors were recorded. E-test was preferable to checkerboard method for the total cost (reagent cost + cost of technologist time) (8,60 vs 21,80 euros/test, respectively). E-test appeared a promising alternative for testing antibiotic combinations although further testing should be performed to better refine this metodology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15460529

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  2 in total

1.  Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates.

Authors:  G Samonis; S Maraki; D E Karageorgopoulos; E K Vouloumanou; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-31       Impact factor: 3.267

2.  Association between Beta-lactam Antibiotic Resistance and Virulence Factors in AmpC Producing Clinical Strains of P. aeruginosa.

Authors:  Sanaz Dehbashi; Hamed Tahmasebi; Mohammad Reza Arabestani
Journal:  Osong Public Health Res Perspect       Date:  2018-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.